| Net loss | -1.95M |
| Depreciation | 227.11K |
| Amortization | 60.54K |
| Deferred rent | 5.72K |
| Non-cash stock-based compensation expense | 36.72K |
| Loss on disposal of assets | |
| Non-cash warrant expense | |
| Change in fair value of warrants | 0 |
| Accounts receivable | 57.8K |
| Inventories | -1.09M |
| Prepaid expenses and other assets | 27.34K |
| Accounts payable and book overdrafts | 471.66K |
| Accrued expenses | |
| Net cash (used in) provided by operating activities | -1.67M |
| Purchase of property and equipment | -41.7K |
| Net cash used in investing activity | -41.7K |
| Net borrowings (repayments) under line of credit | 1.81M |
| Decrease (increase) in restricted cash | -96.94K |
| Principal payments on capital lease obligations | 0 |
| Proceeds from exercise of stock options | |
| Net cash provided by (used in) financing activities | 1.71M |
| Net increase (decrease) in cash | -400 |
| Cash beginning of period | 64.65K |
| Cash end of period | 64.25K |
| Conversion of Series B convertible preferred stock to common stock | |
| Disposal of property and equipment | 97.67K |